netFormulary NHS
Buckinghamshire Formulary
Buckinghamshire Healthcare NHS Trust
Buckinghamshire CCG
 Search
 Formulary Chapter 6: Endocrine system - Full Section
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
06.01 Drugs used in diabetes (0,0)
06.01.01 Insulins (2,0)
06.01.01.01 Short-acting insulins (6,5)
06.01.01.02 Intermediate- and long-acting insulins (7,7)
Biphasic insulins (3,6)
06.01.01.03 Hypodermic equipment (3,0)
06.01.02 Antidiabetic drugs (0,0)
06.01.02.01 Sulphonyureas (4,5)
06.01.02.02 Biguanides (4,2)
06.01.02.03 Other antidiabetic drugs (16,9)
06.01.03 Diabetic ketoacidosis (0,0)
06.01.04 Treatment of hypoglycaemia (6,1)
Chronic hypoglycaemia (2,0)
06.01.05 Treatment of diabetic nephropathy and neuropathy (0,0)
Diabetic nephropathy (0,0)
Diabetic neuropathy (0,0)
06.01.06 Diagnostic and monitoring agents for diabetes mellitus (0,0)
Blood glucose monitoring (23,1)
Blood glucose strips recommended for type 2 diabetes (excluding pregnancy) (0,0)
Blood glucose testing strips for gestational diabetes (0,0)
Blood glucose testing strips for type 1 diabetes - for meters that can also measure ketones (0,0)
Blood test strips which measure ketones alone (0,0)
Lancets (0,0)
Syringes and needles (used for vials of insulin) (0,0)
Needles (used for insulin pens) (0,0)
Autoinjection needles (0,0)
Urinalysis (7,7)
Oral glucose tolerance test (1,2)
06.02 Thyroid and Antithyroid drugs (0,0)
06.02.01 Thyroid hormones (4,1)
06.02.02 Antithyroid drugs (3,0)
06.03 Corticosteroids (0,0)
06.03.01 Replacement therapy (1,0)
06.03.02 Glucocorticoid therapy (16,4)
Disadvantages of corticosteroids (0,0)
Use of corticosteroids (0,0)
Pregnancy and breastfeeding (0,0)
Administration (0,0)
Withdrawal of corticosteroids (0,0)
06.04 Sex hormones (0,0)
06.04.01 Female sex hormones and their modulators (0,1)
06.04.01.01 Oestrogens and HRT (15,29)
Hormone replacement therapy (0,0)
Ethinylestradiol (0,1)
Raloxifene (1,0)
06.04.01.02 Progestogens and progesterone receptor modulators (5,1)
06.04.02 Male sex hormones and antagonists (7,5)
Anti-androgens (2,1)
06.04.03 Anabolic steroids (2,0)
06.05 Hypothalamic and pituitary hormones and anti-oestrogens (0,1)
06.05.01 Hypothalamic and anterior pituitary hormones and anti-oestrogens (0,0)
Anti-oestrogens (2,0)
Anterior pituitary hormones (6,7)
Hypothalmic hormones (2,2)
06.05.02 Posterior pituitary hormones and antagonists (2,0)
Posterior pituitary hormones (6,0)
Antidiuretic hormone antagonists (0,0)
06.06 Drugs affecting bone metabolism (0,0)
Osteoporosis (0,0)
06.06.01 Calcitonin and parathyroid hormone (4,1)
06.06.02 Bisphosphonates and other drugs affecting bone metabolism (0,0)
Bisphosphonates (12,5)
Denosumab (2,1)
Strontium ranelate (1,0)
06.07 Other endocrine drugs (0,0)
06.07.01 Bromocriptine and other dopaminergic drugs (2,1)
06.07.02 Drugs affecting gonadotrophins (1,3)
Gonadorelin analogues (6,4)
06.07.03 Metyrapone (1,1)
06.07.04 Somatomedins (0,1)
netFormulary